ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Science Policcy: HHS Concludes NIH May und Human Stem Cell REsearch

January 22, 1999

NCI Ends Brash Foray Into the News Business—Emails Tell the Story of the NCI Cancer Bulletin

February 1, 2013

ACCC Honors Hammond, Murphy

October 19, 2001

Board Oks Construction PA Fro Breast Cancer Research Facilities

July 9, 1993

In Brief: Relocation Of NCI Offices Nearly Complete; Hungary’s Eckhardt UICC President elect

November 4, 1988

NHGRI Director Francis Collins To Step Down.

May 30, 2008